The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.
 
Nancy Chan
No Relationships to Disclose
 
Daniella E. Portal
No Relationships to Disclose
 
Rebecca Anne Moss
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Ann W. Silk
Consulting or Advisory Role - Merck
Research Funding - Amgen (Inst); Biohaven Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Prometheus (Inst); Viralytics (Inst)
 
Mark N. Stein
Consulting or Advisory Role - Exelixis; Exelixis; Merck Sharp & Dohme
Research Funding - Advaxis (Inst); Bristol-Myers Squibb (Inst); Genocea Biosciences (Inst); Harpoon (Inst); Janssen Oncology (Inst); Lilly (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Oncoceutics (Inst); Seagen (Inst); Suzhou Kintor Pharmaceuticals (Inst); Xencor (Inst)
 
Joseph Aisner
Speakers' Bureau - Merck Serono
 
Jyoti Malhotra
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - BeyondSpring Pharmaceuticals (Inst); Biohaven Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst)
 
Weichung Shih
Consulting or Advisory Role - Merck
 
Hongxia Lin
No Relationships to Disclose
 
Michael P. Kane
No Relationships to Disclose
 
Janice M. Mehnert
Honoraria - EMD Serono; Pfizer/EMD Serono
Consulting or Advisory Role - Amgen; Array BioPharma; Array BioPharma; Boehringer Ingelheim
Research Funding - Amgen (Inst); AstraZeneca (Inst); Immunocore (Inst); Incyte (Inst); macrogenics (Inst); macrogenics (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - EMD Serono; Merck Sharp & Dohme
Other Relationship - Amgen; Array BioPharma; Boehringer Ingelheim; EMD Serono; Merck; Merck
 
Antoinette R. Tan
Honoraria - Agendia
Consulting or Advisory Role - Abbvie; Celgene; Genentech/Roche; immunomedics; Novartis; Pfizer
Research Funding - Abbvie (Inst); Advaxis (Inst); Bayer/Onyx (Inst); Eisai (Inst); G1 Therapeutics; Genentech (Inst); Genentech/Roche; GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Caris Centers of Excellence; Caris Centers of Excellence; Caris Life Sciences